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Abstract
For mapping complex disease traits, linkage studies are often followed by a case-control association
strategy in order to identify disease-associated genes/single-nucleotide polymorphisms (SNPs).
Substantial efforts are required in selecting the most informative cases from a large collection of
affected individuals in order to maximize the power of the study, while taking into consideration
study cost. In this article, we applied and extended three case-selection strategies that use allele-
sharing information method for families with multiple affected offspring to select most informative
cases using additional information on disease severity. Our results revealed that most significant
associations, as measured by the lowest p-values, were obtained from a strategy that selected a
case with the most allele sharing with other affected sibs from linked families ("linked-best"),
despite reduction in sample size resulting from discarding unlinked families. Moreover, information
on disease severity appears to be useful to improve the ability to detect associations between
markers and disease loci.
Background
Linkage analyses are often the first step in mapping genes
for complex traits. However, such methods typically
implicate broad regions of the genome, and identifying
causal genes remains a challenge. Association methods,
which rely on linkage disequilibrium (LD) information,
have a much better resolution. Therefore, one may want
to follow a linkage peak with a case-control study to iden-
tify the exact causal variants in a region implicated by link-
age analysis. To reduce the cost and increase the power of
detecting a disease-marker association, different strategies
have been exploited previously to identify genetically
"loaded" individuals by choosing subjects with history of
disease [1], a more severe form of disease [2], or early
onset of disease [3] to increase the chance of detecting
genetic risk factors in a population. Fingerlin et al. [4] pro-
posed four strategies for selecting cases from families with
multiple affected siblings to use in a case-control design in
the search of disease susceptibility genes. In this paper, we
apply and extend their methods to select the most inform-
ative cases using additional information on disease sever-
ity. Our goal is to choose individuals who maximize the
expected difference in allele frequency between cases and
controls.
Methods
Sample population and study design
An initial nonparametric genome scan was conducted in
each of the 4 populations separately on a replicate
selected at random (replicate 71), resulting in two regions
linked to a simulated behavioral disorder. The first region
was identified in the Karangar population on chromo-
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some 9 at marker C09R0765; the second peak was located
on chromosome 1 at marker C01R0052 in the Danacaa
population. Both of these regions were worthy of more
detailed scrutiny in the search for disease susceptibility
loci. Both populations comprised 100 nuclear families
with multiple affected offspring. Once regions linked to
the trait were identified, 34 additional single-nucleotide
polymorphisms (SNPs) were included under each of the
linkage peaks: packets 417 and 418 under the chromo-
some 9 linkage peak and packets 28 and 29 under the
linkage peak on chromosome 1. Allele-sharing probabili-
ties were computed and a SNP genome scan analysis was
carried out, with 91 SNP markers on chromosomes 9 and
95 SNP markers on chromosome 1. The additional pack-
ets of SNPs came with 50 controls for each replicate. We
"collected" a sample of 100 unrelated controls by ran-
domly selecting two replicates (71 and 35). The controls
were not matched to any population because population
admixture was not introduced into the simulations (allele
frequencies are the same across all populations).
The disease of interest was a simulated behavioral disor-
der. In addition, presence or absence of 12 behavioral
characteristics that may be related to the disease were also
provided. We constructed a "severity" index for each indi-
vidual by counting the number of characteristics present.
In some instances we used this severity index in our case
selection.
Case-selection strategies
Fingerlin et al. [4] compared three case-selection strategies
that use allele-sharing information with the standard
strategy that selects a single individual from each family at
random. In our study, we extended these strategies by
using additional information on disease severity.
We considered the following 6 case-selection strategies to
choose one case per sibship: i) a randomly selected case
(all-random, or AR); ii) a case showing most identity-by-
descent (IBD) sharing with other affected sibs (all-best, or
AB); iii) a case with the most severe disease, i.e., with the
highest severity index (all-most-severe, or AMS); iv) a ran-
domly selected case per linked family (nonparametric
linkage (NPL) LOD ≥ 0) (linked-random, or LR); v) a case
with the most IBD sharing with other affected sibs from
linked families only (linked-best or LB); vi) a case with the
most-severe disease chosen from linked families (linked-
most-severe, or LMS).
Table 1: Description of sibships
Sibship size n sibs n affected n unaffected
Danacaa population
0 0 0 10
1 0 0 14
2 10 85 16
3 12 12 21
4 15 2 11
5 19 1 12
6 13 0 8
7 13 0 8
8 5 0 0
9 13 0 0
Total 100 100 100
Karangar population
0 0 0 0
1 0 0 9
2 0 54 19
3 0 34 18
4 17 9 19
5 15 3 12
6 24 0 7
7 16 0 8
8 7 0 7
9 7 0 1
10 12 0 0
11 1 0 0
12 1 0 0
Total 100 100 100
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Selecting families on the basis of multipoint linkage 
information
The software MERLIN [5] was used to calculate the Kong
and Cox NPL LOD score for the entire sample [6]. The 34
additional genotyped SNPs were integrated into the map
on both chromosomes 1 and 9. The "-npl" options was
used to obtain summary LOD scores at each marker loca-
tion. The "-perFamily" option along with "-npl" was used
to obtain specific LOD scores for each family. We defined
a family as showing evidence for linkage if the pedigree
LOD score at the peak marker was ≥ 0. In this definition,
families with less sharing than expected under no linkage
were excluded.
Selecting one sib with the most evidence for sharing with 
other affected sibs
We used the software MERLIN to calculate the amount of
allele sharing between each pair of affected individuals in
a family at each SNP marker under the linkage peak. The
individual(s) with the most allele sharing obtained the
highest "case-score" statistics in each family. There were
38 SNP markers under the linkage peak on chromosome
1 and 9, respectively. Therefore, each affected individual
obtained 38 "case-scores". If there were two or more sibs
with the same allele sharing score or the same severity,
one of them was randomly selected. To minimize chance
results from a specific random selection, 100 iterations
were carried out to obtain an average test statistic.
Test statistics
Allele frequencies were calculated on selected cases and
controls for 38 SNPs on chromosomes 1 and 9. For each
SNP, a chi-square test was performed to determine if there
was a significant difference in allele frequencies between
the selected cases and controls. The averaged chi-square
statistics over 100 iterations were used to compute p-val-
ues for different case-selection strategies; p-values < 0.05
were considered statistically significant.
Results
Description of sibships and severity score index in both 
population
Table 1 describes the sibships in Danacaa and Karangar
population. Most nuclear families had exactly two
affected siblings. The Karangar included more families
with multiple affected (≥ 2) individuals. The severity score
index in unaffected and affected subjects (linked and
unlinked) is summarized in Table 2. As expected, affected
individuals had a much higher severity score than unaf-
fected; however, individuals from linked and unlinked
families had similar severity scores.
Linkage analysis and IBD state calculation
After the additional 34 SNPs were integrated into the map,
the peak NPL LOD score of 4.75 was found at marker
B01T0559 at 168.36 cM on chromosome 1 and of 7.47
was found at marker B09T8335 at 5.45 cM on chromo-
some 9.
The most informative affected individuals were selected
on the basis of linkage, allele sharing, and severity (see
Methods). In both populations, AR, AB, and AMS include
one affected individual from each of the 100 families. The
LR, LB, and LMS selection have sample sizes of 75 and 73
for the Danacaa and Karangar populations respectively,
which correspond to the number of linked families.
Difference in allele frequencies on each marker location
Figure 1 displays chi-square test results (negative loga-
rithm base 10 of the p-value) to detect difference in allele
frequencies for 38 SNPs between cases and controls using
the 6 strategies in Karangar and Danacaa populations. The
horizontal dashed lines on both figures denote p-values of
0.05, 0.01, and 0.001, respectively. The regions between
the vertical dashed lines represent the haplotype region
containing the disease locus on each chromosome. The
data were generated from disease susceptibility haplo-
types; thus, a single causal SNP is not available.
Table 2: Severity score index in unaffected and affected (linked and unlinked) in Danacaa and Karangar population
Danacaa population Karangar population
Sample size Severity score mean (Q3-Q1)* Sample size Severity score mean (Q3-Q1)*
All unaffected 317 1.15 (2) 239 1.27 (2)
All affected 220 5.47 (1) 222 7.41 (1)
Linked 166 5.59 (1) 161 7.34 (1)
Unlinked 54 5.09 (1) 61 7.60 (1)
Control 100 0.70 (1) 100 0.70 (1)
*Q3-Q1: interquartile range
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Results of chi-square test to detect differences in allele frequency between cases and controls using six case-selection strate-giFig re 1
Results of chi-square test to detect differences in allele frequency between cases and controls using six case-
selection strategies. The six case-selection strategies are: i) a randomly selected case (AR); ii) a case showing most IBD shar-
ing with other affected sibs (AB); iii) a case with the most severe disease (AMS); iv) a randomly selected case per linked family 
(LR); v) a case with most IBD sharing with other affected sibs from linked families only (LB); vi) a case with the most-severe dis-
ease chosen from linked families only (LMS). The horizontal dashed lines on both figures denote p-values of 0.05, 0.01, and 
0.001, respectively. The regions between the vertical dashed lines represent the haplotype region containing the disease locus.
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Both figures reveal that smallest p-values were obtained
from the LB selection strategy, despite reduction in sample
size from using individuals in linked families only. Three
SNPs (one on chromosome 1 and two on chromosome 9)
that yielded significant association reside outside the hap-
lotype regions. These may be type I errors. The figures also
indicate that using information on disease severity
appears to improve the ability for detecting association
between markers and disease loci. On chromosome 1, all
significant SNPs using the AMS selection were within the
haplotype region.
Discussion
Our results indicate that more efficient case-control study
designs could be obtained by selecting cases with the most
evidence for allele sharing in addition to linkage informa-
tion, and possibly incorporating information on disease
severity. Despite the decrease in sample size resulting
from exclusion of unlinked families, effect size, as meas-
ured by the chi-square statistic comparing allele frequency
in the cases and controls, can be increased by using this
information.
We initiated our study to identify disease-associated SNPs
in those two chromosome regions based solely on results
from the initial genome scan without more information
about the data or how the disease locus was simulated.
Among our 6 selection strategies, the LB method yielded
smallest p-values on both chromosomes, despite a
decrease in sample size resulting from exclusion of
unlinked families. Our results also indicated that most of
the SNPs that had significant p-values resided within the
simulated haplotype regions. The extension of using
information on disease severity seems to improve the pre-
cision of detection, since no type I errors were observed
using AMS on chromosome 1. In Figure 1, none of the sig-
nificant p-values would remain significant after adjusting
for testing multiple SNPs. However, the sample size used
in this study is very small (N ≤ 100 cases). Therefore, it is
likely to be a powerful strategy for larger sample sizes.
The strategies in our study are most useful if there are
causal SNPs and markers in LD with these SNPs, or the
causal variants themselves have been genotyped. In the
Genetic Analysis Workshop 14 data, disease status was
simulated from haplotypes and the causal variants them-
selves were not available. On chromosome 1, the maxi-
mum estimated r2 (pair-wise) value was only 0.03, which
indicated virtually no LD was present. On chromosome 9,
the two largest r2 values were 0.87 (between B09T8338
and B09T8339) and 0.56 (between B09T8337 and
B09T8338), respectively, indicating a region with higher
LD values. However, neither of those SNPs reached statis-
tical significance at the 0.05 level. In the absence of
knowledge of the LD pattern between the tested SNPs and
the causal SNP, it is difficult to make general conclusions
from the current study. Nevertheless, some interesting
results emerged from our analyses. Extension of the case
selection strategy to take haplotype information into con-
sideration may be more successful. We are exploring such
extensions.
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